Exhale

The official blog of the Lung Institute.

Lung Institute Supports Pulmonary Fibrosis Awareness Day with Unique Plea to the Public

4 Sep 2013
| Under Press | Posted by | 0 Comments
Pulmonary Fibrosis Awareness Day

On September 7th, at 1 p.m., Hold Your Breath as Long as You Can for Pulmonary Fibrosis Awareness Day

Tampa, FL (September 4, 2013) – In honor of Global Pulmonary Fibrosis Awareness Day, Tampa-based stem cell provider Lung Institute is asking the general public to participate in an event called A Breathless Moment.

When: Saturday, September 7th at 1 p.m.

Why:  The time of 1 p.m. was chosen to represent living with the capacity of only one lung, and the exercise of holding one’s breath as long as possible shows non-sufferers what it feels like to live with this disorder every minute of every day.

Pulmonary Fibrosis Facts:

  • The disease affects approximately 140,000 people in the US.
  • An estimated 50,000 new cases are diagnosed each year, with no known cause.
  • Pulmonary fibrosis can strike anyone, but the disease tends to occur between the ages of 50 and 75.

“Pulmonary fibrosis is a debilitating disease that leaves sufferers with limited options,” said Lynne Flaherty, Director of Operations at the Lung Institute. “At LI, we not only provide innovative treatments that aid in the restoration of damaged lung tissues, we strive to raise awareness about different forms of lung disease, like pulmonary fibrosis.”

About Lung Institute

The Lung Institute is a leading medical provider of regenerative cellular therapy for lung diseases such as COPD, pulmonary fibrosis and interstitial lung disease. Founded in 2013 in Tampa, Fla., the Lung Institute currently has clinics in Tampa, Fla., Nashville, Tenn., Scottsdale, Ariz., Pittsburgh, Pa. and Dallas, Texas. For more information, please visit www.lunginstitute.com or call (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.